Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Disease or Syndrome
2
112
0.710
None
1.000
26
112
1993
2018
Hyperammonemia
phenotype
Pathological Conditions, Signs and Symptoms
Disease or Syndrome
102
8
0.500
None
0.957
23
2
1993
2019
Urea Cycle Disorders, Inborn
group
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Disease or Syndrome
14
0.070
None
1.000
7
2007
2018
Glomerular Filtration Rate
phenotype
Diagnostic Procedure
399
1033
0.100
None
1.000
7
3
2016
2019
Creatinine measurement, serum (procedure)
phenotype
Laboratory Procedure
124
243
0.100
None
1.000
5
3
2010
2019
×
CUI:
C0030193
Disease:
Pain
Pain
phenotype
Pathological Conditions, Signs and Symptoms
Sign or Symptom
1554
196
0.040
None
1.000
4
2014
2018
Fibrinogen assay
phenotype
Laboratory Procedure
55
143
0.100
None
1.000
4
3
2009
2017
Kidney Failure, Chronic
disease
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
Disease or Syndrome
827
425
0.100
None
1.000
4
2
2010
2019
Herpes zoster disease
group
Infections
Disease or Syndrome
51
10
0.040
None
1.000
4
2014
2019
High density lipoprotein measurement
phenotype
Laboratory Procedure
545
1440
0.100
None
1.000
3
1
2013
2019
Carbamoyl Phosphate Synthase 1 Deficiency
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Disease or Syndrome
3
0.310
None
1.000
3
1993
2007
Postherpetic neuralgia
disease
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
Disease or Syndrome
24
1
0.030
None
1.000
3
2014
2019
Chronic Kidney Diseases
group
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
Disease or Syndrome
1074
306
0.110
None
1.000
3
1
2010
2018
Finding of Mean Corpuscular Hemoglobin
phenotype
Finding
653
1206
0.100
None
1.000
3
1
2016
2019
Amino acids measurement
group
Laboratory Procedure
53
92
0.100
None
1.000
3
2
2015
2019
Necrotizing enterocolitis in fetus OR newborn
disease
Digestive System Diseases
Disease or Syndrome
210
26
0.030
None
1.000
3
2
2007
2016
Liver carcinoma
disease
Digestive System Diseases; Neoplasms
Neoplastic Process
5725
942
0.030
None
1.000
3
2002
2014
Homocysteine measurement
phenotype
Laboratory Procedure
23
33
0.100
None
1.000
3
2
2010
2014
Glycine measurement
phenotype
Laboratory Procedure
32
68
0.100
None
1.000
3
3
2019
2019
HHH syndrome
disease
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Disease or Syndrome
8
21
0.030
None
1.000
3
2018
2019
Liver Failure
disease
Digestive System Diseases
Disease or Syndrome
293
20
0.200
None
1.000
2
1996
2002
Drug-Induced Liver Disease
phenotype
Digestive System Diseases; Chemically-Induced Disorders
Disease or Syndrome
537
29
0.310
None
1.000
2
2015
2015
Metabolic Diseases
group
Nutritional and Metabolic Diseases
Disease or Syndrome
945
50
0.020
None
1.000
2
1998
2019
Intrahepatic Cholangiocarcinoma
disease
Neoplasms
Neoplastic Process
470
19
0.020
None
1.000
2
2015
2019
Adenocarcinoma of lung (disorder)
disease
Neoplasms
Neoplastic Process
2438
563
0.020
None
1.000
2
2017
2019